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BRUCELLA SPECIES SURVEY IN POLAR BEARS (URSUS
MARITIMUS) OF NORTHERN ALASKA
Todd M. O’Hara,1,5 Darce Holcomb,1 Philip Elzer,2,3 Jessica Estepp,4 Quinesha Perry,3
Sue Hagius,2 and Cassandra Kirk1

ABSTRACT:
We report on the presence of specific antibodies to Brucella spp. and Yersinia
enterocolitica in polar bears (Ursus maritimus) from northern Alaska (southern Beaufort Sea)
during 2003–2006. Based on numerous known stressors (e.g., climate change and loss of sea ice
habitat, contaminants), there is increased concern regarding the status of polar bears. Considering
these changes, it is important to assess exposure to potentially pathogenic organisms and to
improve understanding of transmission pathways. Brucella or specific antibodies to Brucella spp.
has been reported in marine mammals. Various assays were used to elucidate the pathway or
source of exposure (e.g., ‘‘marine’’ vs. ‘‘terrestrial’’ Brucella spp.) of northern Alaska polar bears to
Brucella spp. The standard plate test (SPT) and the buffered Brucella antigen card test (BBA) were
used for initial screening for antibodies specific to Brucella. We then evaluated positive reactors
(presence of serum antibody specific for Brucella spp.) using immunoblots and competitive
enzyme-linked immunosorbent assay (cELISA; based on pinniped-derived Brucella spp. antigen).
Annual prevalence of antibody (BBA and SPT) for Brucella spp. ranged from 6.8% to 18.5% over
2003–2006, with an overall prevalence of 10.2%. Prevalence of Brucella spp. antibody did vary by
age class. Western blot analyses indicated 17 samples were positive for Brucella spp. antibody; of
these, 13 were negative by marine (pinniped) derived Brucella antigen cELISA and four were
positive by marine cELISA. Of the four samples positive for Brucella antibody by marine cELISA,
three cross-reacted with Y. enterocolitica and Brucella spp. (one sample was Brucella negative and
Y. enterocolitica positive). It appears the polar bear antibody does not react with the antigens used
on the marine cELISA assay, potentially indicating a terrestrial (nonpinniped) source of Brucella
spp.
Key words: Alaska, Brucella, polar bear, serology, Ursus maritimus, Western blot, Yersinia
enterocolitica.

reproductive tissues or close contact with
infected animals. There are six classical
Brucella species: Brucella abortus, Brucella melitensis, Brucella suis (biovar 1, 2, 3,
4), Brucella ovis, Brucella canis, and
Brucella neotomae (Fraser, 1991). A
unique Brucella-like organism has been
isolated from a captive bottlenose dolphin
(Tursiops truncatus) in California (Ewalt
et al., 1994) and from other marine
mammals (Ross et al., 1994; Nielson et
al., 1996, 2001, 2005; Jahans et al., 1997;
Clavereau et al., 1998; Bricker et al., 2000;
Cloeckaert et al., 2001; Tryland et al.,
2001; Rah et al., 2005).
Because polar bears prey on both
terrestrial and marine mammals (Derocher and Wiig, 1999; Derocher et al.,

INTRODUCTION

Brucellosis occurs globally in a variety
of domestic animals as well as in terrestrial
and marine wildlife. Although infection is
rarely fatal, it may cause abortions, infertility, bursitis, arthritis, orchitis, or osteomyelitis (Davis 1990; Enright 1990; Ross
et al., 1994; Brew et al., 1999). Evidence
of Brucella in terrestrial wild mammals in
Alaska includes both serology and culture
(O’Hara et al. 1998; Edmonds et al., 1999;
Zarnke et al., 2001, 2006). Brucellosis also
has been reported in humans in Alaska
(Gilbertson et al., 2005; Butler and
McLaughlin, 2007). The organism is
highly contagious and is transmitted in
wildlife through exposure to infected
687
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MATERIALS AND METHODS
Study area and sample population

As recently reported (Bentzen et al., 2007),
the southern Beaufort Sea population of polar
bears ranges along the north coast of Alaska
and Canada from Point Lay (163uW) to Cape
Perry in Amundsen Gulf (125uW). The bears
extend north along Banks Island to Prince
Patrick Island, Canada (Bethke et al., 1996;
Paetkau et al., 1999; Amstrup et al., 2000).
There is some movement among populations
and geographic overlap of adjacent populations. For example, near Pt. Barrow, bears
have about a 50% chance of originating from
the southern Beaufort or Chukchi sea stock
(Amstrup et al., 2004). Moving east along the
coast of northern Alaska, population mixing
becomes less pronounced (Amstrup et al.,
2005). Polar bears in the southern Beaufort
Sea remain primarily on the ice throughout
the year (Garner et al., 1990; Scribner et al.,
1997; Amstrup et al., 2000), congregating
along ice edges (Durner et al., 2004). Some
bears move to coastal areas in the winter for
feeding (e.g., Bentzen et al., 2007).
Bears were captured up to 80 km offshore in
the area between Barrow and Demarcation
Point (69u709N, 141u009W; Bentzen et al.,
2007). Polar bears were captured utilizing
intramuscular immobilizing drugs contained in
projectile syringes fired from a helicopter
using Cap-chur equipment (Palmer Chemical
Co., Douglasville, Georgia, USA), with a
200mg/mL solution of tiletamine hydrochloride and zolazepam hydrochloride (8–9 mg per
kg of body weight, TelazolH, Warner-Lambert
Co., Plains, New Jersey, USA; Stirling et al.,

1989; Amstrup et al., 2000, 2001). Sampling
mostly occurred from March through April,
2003–2006. Capture procedures were approved under the University of Alaska Fairbanks IACUC approval 04-58. Age determination was conducted as in Bentzen et al.
(2007). Age classes were designated according
to life history stages described for Alaska
Beaufort Sea polar bears (Amstrup, 2003).
Polar bears reach sexual maturity between 3
and 5 yr, typically becoming reproductively
active at 5 yr of age. Young are estimated to be
weaned at 2.3 yr, with adults reaching
reproductive senescence at approximately
20 yr of age. Polar bears aged 1–5 yr were
designated as subadults; bears aged 6–15 yr
were recorded as adults; bears aged 16 yr and
older were considered postprime adults.
Sample collection and assays

Blood (5 ml) was collected from the femoral
vein or artery of 45 polar bears (21 females
and 24 males) in spring 2003, 103 bears (44
females and 59 males) in 2004, 54 bears (33
females and 21 males) in 2005, and 73 bears
(30 females and 43 males) in 2006. Serum
samples were collected and transported under
USFWS permit (MA690038-9). Serum was
separated from blood by centrifugation at
approximately 4,200 3 G (3,500 rpm, TRIAC,
Clay Adams Co., Parsippany, New Jersey,
USA) for 5 min and frozen at 220 C; sera
were stored at 270 C upon return from the
field. Samples were tested (screened) using
buffered Brucella antigen card test (BBA or
card test) and standard plate test (SPT).
Samples were considered positive if both
BBA and SPT were positive. A subsample of
positive, negative, and suspect (only positive
on BBA or SPT) samples were tested using a
direct binding assay (Western blot analysis) to
detect antigens to terrestrial Brucella spp. as
described by Edmonds et al. (1999). Cell
lysates used in the Western blot analyses
included B. abortus 2308; RB51, a rough
mutant of 2308; B. melitensis 16M; B. suis
biovar 4; VTRS1, a rough strain of B. suis; and
Y. enterocolitica 0:9 and 0:8. The Western blot
is a sensitive direct binding assay able to detect
as little as 1 ng of protein (Harlow and Lane,
1988).
Competitive enzyme-linked immunosorbent assay

Sera were sent to the University of Southern
Mississippi, Hattiesburg, Mississippi, USA and
were tested using a marine (pinniped) brucellosis specific competitive enzyme-linked immunosorbent assay (cELISA) as described by
Estepp (2005). The standard Brucella antigen
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2000; Bentzen et al., 2007) they could be
exposed to terrestrial and marine Brucella
through intraspecific contact or food. The
objectives of this study were to: 1)
determine prevalence of Brucella-specific
antibody in polar bears during 2003–2006;
2) assess whether polar bears are likely
exposed to terrestrial (e.g., B. abortus or
B. suis biovar 4) or marine varieties (e.g.,
reactivity with antigens of Brucella organisms of pinniped host origin); 3) use
Western blot analysis to determine whether polar bears exposed to a terrestrial
variety react with B. abortus or B. suis
biovar 4; and 4) assess cross-reactivity with
Yersinia enterocolitica antigen using Western blot.
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Reference samples from other species

Non–polar bear carnivore samples were
evaluated for comparison representing animals
from Alaska and non-Alaska marine species.
From Alaska we evaluated 118 black bears
from the region near McGrath in 2003 (93)
and 2004 (25). Brown bear (92) samples were
collected from Nelchina (35), Deadhorse (48
from GMU 26A, B, and C), and GMU 15 A
and B in the northern Kenai Peninsula area
(9). Bottlenose dolphins (32) from Sarasota
Bay, Florida, were tested. Samples from the
Alaskan mammals were provided by ADFG
(K. Beckmen), and dolphin samples were
provided by the Chicago Zoological Society
(R. Wells). We do not provide a map or more
detailed location data because these are not
assessed as populations but serve as reference
samples for the assays.
Data analyses

Prevalence was calculated based on total
number of positive (positive for both BBA and
SPT) bears tested per year and for the entire
2003–2006 period; 95% confidence interval
(CI) were calculated as described in HughesHanks et al. (2005). The Fisher exact test was
used to test for homogeneity in prevalence
between sampling years, gender, and age class.
The cELISA data were analyzed by bootstrapping (Efron and Gong, 1983). Prior to
applying the bootstrapping, the optic density
(OD) values were adjusted by subtracting
values for the respective controls for those
dilutions to account for any nonspecific
binding that may have occurred. Bootstrapped

OD values were plotted versus dilution. The
titer was defined as the highest dilution at
which 50% competition occurred, that is,
where at least a 50% reduction of the
maximum absorbance was obtained in comparison to the minimum absorbance. Maximum absorbance would normally occur in the
absence of any anti-Brucella antibody, that is,
in negative control samples, whereas the
minimum absorbance obtained normally occurred in a series of the lower dilutions of
samples.
RESULTS
Polar bear samples

Twenty-eight of 275 (10.2%) polar bear
serum samples collected from 2003
through 2006 were positive by SPT and
BBA (Table 1). Antibody prevalence did
not differ among years (P.0.05), but did
vary by age class (P50.04; Table 1).
Results from other mammals in Alaska
and bottlenose dolphins are reported as
well.
Twenty of the 28 Brucella spp. antibody-positive samples were further tested
by Western blot and the marine (pinniped) specific cELISA (Tables 2, 3). The
Western blot was used to detect terrestrial
Brucella spp. only. Seventeen of the 20
samples had detectable antibodies to
terrestrial Brucella spp., whereas three
(15%, three of 20) were negative (due to a
cross-reaction with Y. enterocolitica in
BBA and SPT). Of the 17 samples with
detectable antibodies to Brucella spp. in
the BBA, SPT and Western blot analyses,
only four (24%, four of 17) were positive
for marine (pinniped)-specific Brucella by
cELISA (Table 3). However, three of
those four samples were also positive for
antibodies for Y. enterocolitica, suggesting
cross-reactions in the cELISA (Table 3
includes Y. enterocolitica). One polar bear
serum sample (duplicate samples) resulted
in a titer of 1:5,120 via cELISA.
Samples from other mammal species

Overall, brown bears had a 14% (95%
CI, 8–23%) prevalence of antibody to
Brucella, whereas black bears showed a

Downloaded from http://meridian.allenpress.com/doi/pdf/10.7589/0090-3558-46.3.687 by Louisiana State University - Baton Rouge user on 14 January 2022

preparation used in the cELISA was a heatkilled suspension of Brucella sp. (originally
isolated from a harbor seal [Phoca vitulina]) to
contain 13108 cells/ml; 50 ml of the antigen
preparation was added to each well of a 96well plate and serum was diluted serially in
phosphate-buffered saline (PBS) and added to
the appropriate wells (50 ml), with each set of
wells in a column receiving one of the
dilutions. A 1:100 dilution of a preparation of
biotinylated rabbit anti-Brucella (University of
Southern Mississippi) in PBS was added to the
appropriate wells (50 ml). A predetermined
working dilution (ranging from 1:1,000 to
1:6,000) of ExtrAvidinH-labeled alkaline phosphatase (Sigma-Aldrich, St. Louis, Missouri,
USA) was diluted in PBS and added to the
appropriate wells (50 ml). After 30 min incubation at room temperature, the optic density
of each well was read at 405 nm using a
microplate reader (Model ELx808TM, Bio-Tek
Instruments, Inc., Winooske, Vermont, USA).
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TABLE 1. Buffered Brucella antigen and standard plate test results for Alaskan polar bear serum samples
(2003–2006) and other mammals used for comparison or reference.
Species and location or year

No. samples

Brown bears (Alaska)
Russian River
Nelchina
Deadhorse, North Slope GMU 26A, B and C
Unknown location
GMU 15A and B
Total brown bears
Black bears (McGrath, Alaska)
2003
2004
Total black bears
Dolphins
Sarasota, Florida 2006
a

44
103
54
73
275
147
128
96
78
55
22
16

3
8
10
7
28
17
11
14
5
7
1
0

(7)
(7.8)
(19)
(10)
(10.2)
(11.6)
(8.6)
(15)
(6)
(13)
(5)
(0)

1.4–18.7
3.4–14.7
9.3–31.4
3.9–18.8
6.9–14.4
6.9–17.9
4.4–14.9
8.2–23.3
2.1–14.3
5.3–24.5
0.1–22.8
0.0–20.6

1
30
48
5
8
92

0
1
11
0
1
13

(0)
(3)
(23)
(0)
(13)
(14)

0–97.5
0.1–17.2
12.0–37.3
0–52.2
0.3–52.7
7.7–23.0

93
25
118

0 (0)
1 (4)
1 (0.8)

0–3.9
0.1–20.4
0–4.6

32

4 (13)

3.5–29

No. (%) positive. Samples are considered positive if both buffered Brucella antigen test and standard plate test were
positive.

TABLE 2. Numbers of positive (Pos), negative (Neg),
suspect, and inconclusive samples by buffered
Brucella antigen/standard plate test (BBA/SPT) and
Western blot analysis (Brucella status) for 24 serum
samples from free-ranging Alaskan polar bears.

BBA/SPT status

No. Pos
Brucella suis
biovar 4 by
Western blot

Cross-reaction
with Yersinia
entercolitica by
Western blota

Pos BBA/SPT (n517)
Neg BBA/SPT (n53)
Suspect (n53)b
Inconclusive (n51)c
Total (n524)

16
2
2
na
20

1
1
1
na
3

a

95% confidence interval (%)

Cross-reaction with Y. enterocolitica results from a
negative B. suis biovar 4 result, but positive for Y.
enterocolitica antibodies.

b

Suspect tests result from a negative buffered antigen test
and a positive standard plate test.

c

na 5 not available.

much lower prevalence (0.8%; 95% CI, 0–
4.6%). Three brown bears were tested on
cELISA and were negative; based on SPT
and BBA, two were positive for antibodies
to Brucella spp. and one suspect was
positive for antibody to Y. enterocolitica
on Western blot. Black bears positive for
TABLE 3. Numbers of samples positive (Pos) and
negative (Neg) for Western blot and competitive
enzyme-linked immunosorbent assay (marine
cELISA) for 20 serum samples from free-ranging
Alaskan polar bears subject to both analyses.
Marine cELISA
Pos

Neg

Totals

Pos
Neg

4
0

13
3

17
3

Totals

4

16

20

Western blot
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2003
2004
2005
2006
Total
Females
Males
Age 1–5
Age 6–10
Age 11–15
Age 16–20
Age 21+
Non–polar bear species

Positivea
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DISCUSSION

Antibodies to Brucella spp. were detected in polar bears but the actual
prevalence is difficult to determine based
on the tests used as some of the positive
results (detected antibody) may actually
represent cross-reactions with Yersinia
spp. (specificity problem). The results
(three of the serum samples that were
negative on BBA and SPT were antibody
positive for B. suis biovar 4 on the
Western blot) indicate the Western blot
is a more sensitive assay than the BBA and
SPT suggesting potential problem with
sensitivity related to the other assays.
Thus, determining prevalence of antibody
to Brucella spp. in polar bears appears to
be assay dependent (e.g., when considering level of detection and cross-reactivity,
or sensitivity and specificity). About 8% of
reactors using BBA and SPT may be
‘‘positive’’ because of previous exposure
to Y. enterocolitica, indicating a ‘‘crossreaction’’ that explains some of the agglutination. Cross-reactivity in serologic assays between Brucella spp. and Y. enterocolitica has been well documented
(Ahvonen et al., 1969; Hurvell, 1972;
Corbel and Dag, 1973; Marx et al., 1974;
Bundle et al., 1984). The antigens responsible for this cross-reactivity reside in the
O-side chain of the lipopolysaccharides of
the bacteria (Caroff et al., 1984). Marine
varieties of the Brucella genus have been
isolated and characterized by other laboratories (not available for this study).
These species or strains of Brucella

possess different characteristics from the
known terrestrial strains.
The actual Brucella spp. responsible for
seroconversion are unknown. Recent evidence indicates there are likely ‘‘marine’’
varieties of this genus with an unknown
distribution (Ewalt et al., 1994; Ross et al.,
1994; Nielsen et al., 1996; Clavereau et al.,
1998). Western blot analyses indicate that
the most likely terrestrial species involved
was B. suis biovar 4, based on examination
of specific antigens. We emphasize that
these results are not conclusive in that we
are relying on antibody interactions with
known bacterial components and we lack
the specific Brucella spp. components
from organisms originating in polar bears
(assuming host specificity may be important). We also point out the specificity and
sensitivity of the cELISA are unknown.
Serologic assay cross-reactions within and
between genera of bacteria are well known
and likely occurring here, but we focus on
the impact of Yersinia spp. affecting
Brucella spp. assay results. The apparent
specificity for B. suis biovar 4 on Western
blots may be explained by the known
presence of this organism in caribou and
moose of Alaska. We know cross-reactions
between Yersinia spp. and Brucella spp.
occur, but we cannot determine nor
estimate the cross-reactivity of Brucella
spp. as a genus within polar bears, as we
lack an isolate from which to identify
unique components (antigens) for inclusion in developing more specific assays,
especially for the Western blot. That many
of the samples positive by BBA, SPT, and
Western blot analyses (polar bears as well
as other terrestrial mammals from Alaska)
did not react on the marine (pinniped)
cELISA provides strong evidence that the
polar bear–based ‘‘Brucella antigen’’ eliciting the antibody is not related to the
marine source used to develop the marine
cELISA for Brucella spp. However, there
may be some cross-reactivity to Y. enterocolitica antibody with the cELISA. Our
data suggest that the marine cELISA may
have detected antibodies to Y. enterocoli-
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antibody to Brucella spp. based on SPT
and BBA were negative on the cELISA.
Four of the dolphins that were positive for
antibody to Brucella spp. (13%; 95% CI,
4–29%) based on SPT and BBA resulted
in one (titer51:1,280) of the four positive
for antibody on cELISA. A positive control
(T. truncatus) from USM was positive on
this run. Thus, two of five bottlenose
dolphins were positive on the marine
(pinniped) cELISA.
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bears. Our assessments indicate the antibodies may be generated from Brucella
antigen more typical of terrestrial hosts or
a different genus of bacteria (e.g., Yersinia). Attempts at culture and PCR amplification of Brucella spp. to more directly
address this question of single or multiple
species of Brucella in polar bears of Alaska
have not been successful in our studies.
Clearly, isolation of Brucella organism for
characterization is needed, but until then
we are left assessing the antibodies
specific to various Brucella spp. antigens.
We conclude that the prevalence of
Brucella spp. antibodies in polar bears
warrants further investigation with more
attention to possible annual variability.
The source or pathway for the exposure to
Brucella spp. antigen appears to be
terrestrial, not marine, based on the
comparative analyses of various assay
methods and antigens used in this study.
The possibility of exposure to a marine
(ice seal or walrus)–derived Brucella sp.
requires further investigation in polar
bears. One should also consider that the
designation of marine and terrestrial forms
may be complicated by use of coastal
habitats and the overlap of species habitat
and variations in feeding ecology.
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tica, and only one of the 20 positive
samples (based on BBA, SPT, and Western blot) reacted with the marine Brucella
antigen used in the tests. This may
indicate that the species of Brucella to
which the polar bears were exposed is
either terrestrial (B. suis biovar 4) or a
different marine species than that used to
develop the cELISA.
Tryland et al. (2001) reported a prevalence of 5.4% of anti-Brucella spp. antibodies in 297 polar bears (Ursus maritimus) from Svalbard and the Barents Sea.
Rah et al. (2005) found 25 of 500 polar
bears (5%) had antibodies to Brucella spp.
The species of Brucella to which these
polar bears were exposed was not determined. Polar bears are the largest terrestrial carnivore and the apex predator in
the arctic marine food chain. Even though
they are considered terrestrial by some,
their intimate ties with the arctic sea ice
on which they rely for survival contribute
to the notion that they are more of a
marine mammal, especially with respect to
their marine chemical feeding ecology
(Benzten et al., 2007). Although their
main food source consists of seals and
other marine mammals that may carry the
marine strain of Brucella, they also scavenge caribou, moose, and musk oxen,
which have B. suis biovar 4 in Alaska
(Rah et al., 2005). Determining the
species of Brucella to which polar bears
are exposed will help determine the
source. A better understanding of this
and other abortifacients is important to
disease specialists, wildlife managers, and
hunters of polar bears. It is unknown if
prevalence of detectable antibody to
Brucella or Yersinia spp. cycles (e.g.,
varies annually) in this host species.
Animals with antibodies to Brucella spp.
range in prevalence by year from 7% to
19%, with an average of approximately
10% over the sampling period.
Tryland et al. (2001) indicated ringed
seal as an important prey species for the
Svalbard polar bear population and may
thus be a source of brucellosis for the
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